Highlights
-Vitronectin is a glycoprotein that is produced by the liver and respiratory epithelial cells.
-The production of vitronectin is upregulated in patients with cystic fibrosis.
-Airway isolates from patients with cystic fibrosis bind more vitronectin than isolates cultured from blood.
-Porin D is a novel and major vitronectin-binding protein on the surface of P. aeruginosa.
Introduction
The Gram--negative opportunistic pathogen Pseudomonas aeruginosa is responsible for a substantial burden of disease and mortality, particularly for patients with other underlying diseases. P. aeruginosa causes various infections in humans, notably pulmonary infections, keratitis, wound infections and septicemia [1] . It has been shown to be the main pathogen causing increased morbidity and mortality in patients with cystic fibrosis (CF) [2] . P. aeruginosa also associated with a high morbidity in patients with advanced stage of chronic obstructive pulmonary disease (COPD) [3] , and is reported as the most common bacterial species isolated during exacerbations [4] . In parallel, P. aeruginosa is often found as an infectious agent in patients suffering from ventilator associated pneumonia (VAP) [5] . Though P. aeruginosa primarily exists in mucus plugs and sputum plaques during long term colonization of CF patients, it is known to adhere to epithelial cells, exposed basement membrane or other proteins of the extracellular matrix (ECM) [6] .
For both P. aeruginosa and Pseudomonas fluorescence it has been suggested that the ECM protein vitronectin is important for bacterial adherence to respiratory epithelial [7, 8] .
Vitronectin is a plasma protein that exists naturally as a 75 kDa intact protein and a truncated 65 kDa form. It was first discovered for its ability to stick to glass surfaces where subsequently human primary cells could grow [9] . It has later been found to be associated with cell to cell adhesion, wound repair and regulation of the complement system. Furthermore, vitronectin promotes coating on polymer surfaces and it may aid to build up biofilms, as exemplified by coagulase--negative staphylococci on cerebrospinal shunts [10] . During wound healing, vitronectin facilitates mammalian cell adhesion and forms an ECM with other glycoproteins that is attached to mammalian cells throughαvβ5 integrins, which are upregulated during inflammation [11] . Although vitronectin is mainly produced by hepatocytes, it is also released by respiratory epithelial cells and present in the healthy lung [12] . The vitronectin mRNA expression is upregulated in neutrophils derived from patients with CF and the concentration of vitronectin in the airway lumen is increased in patients suffering from sarcoidosis and interstitial lung disease, which may reflect the level of inflammation [13, 14] . The goal of this study was to investigate whether P. aeruginosa has vitronectin--binding surface receptors, and to evaluate the ubiquity of this interaction by screening clinical isolates. Moreover, we also aimed to identify vitronectin--binding proteins at the surface of P. aeruginosa, and to characterize the nature of this interaction in detail. We identified Porin D as the main vitronectin--binding receptor, which is a previously unknown function attributed to this outer membrane protein (OMP).
Material and methods

Bacterial strains and culture conditions
Forty--two clinical P. aeruginosa isolates and the reference strain PAO1 were supplied by the Clinical Microbiology laboratory (Malmö, Sweden) and the Department of Clinical Microbiology at Rigshopitalet (Copenhagen, Denmark) [15] . All isolates were verified as P. aeruginosa by using MALDI--TOF. A transposon insertion mutant was obtained from the P. aeruginosa two--allele library (Washington university, Seattle, WA): PW2742 oprD--E12::ISphoA7/hah [16] . P. aeruginosa was grown on blood agar plates or in liquid Lysogeny broth (LB). E. coli DH5α and E. coli BL21 (DE3) were also cultured in LB medium supplemented with appropriate antibiotics (Table 1 ).
Vitronectin direct binding assay (DBA) 6
Vitronectin was labeled with [ 125 I] using the Chloramine--T method [17] . One loop of P.
aeruginosa was taken from a glycerol stock kept at --80°C and grown overnight on blood agar plates. Bacteria were scraped from the plates and resuspended to OD600=1.0 in phosphate buffered saline (PBS) containing 1 % bovine serum albumin (BSA 
Expression and purification of recombinant proteins
The full--length gene encoding for Porin D (oprD) were amplified from genomic DNA of P. aeruginosa PAO1 using primers 5'--CTGAGGATCCGGACGCATTCGTCAGCGATCAGGCC--3'
and 5'--CTGACAAGCTTCAGGATCGACAGCGGATAGTCGACGATCAG--3'. The amplified gene products were cloned into the expression vector pET26b (Novagen, Darmstadt, Germany), and used for protein expression and purification [19] . The oprD gene was also cloned into pET16b (Novagen) for expression of proteins at the surface of E. coli using primers 5'--TATACGCATATGAAAGTGATGAAGTGGAGCGCCATTGCA--3' and 5'--TCAATTGGATCCTTACAGGATCGACAGCGGATAGTCGA--3'. For expression and purification, E. coli DE3 (Novagen) with the appropriate vector was used. Vitronectin fragments were expressed in HEK 293T cells and purified by a Ni--NTA resin [18] .
Antibody production
Two rabbits were immunized with 200 µg of recombinant protein emulsified in complete Freund´s adjuvant (CFA; Difco and BD Biosciences, Franklin Lakes, NJ). Booster doses were injected on days 18 and 36 with the same dose of protein in incomplete FA.
Blood was drawn three weeks later. Antibodies were purified by CN--bromide agarose conjugated with OprD [20] .
Enzyme--linked immunosorbent assay (ELISA)
Initial protein--protein interactions were analyzed with ELISA. Proteins (50 nM) were coated in 96--well PolySorp ® plates (Thermo Fisher Scientific, Waltham, MA) in coating buffer (100 nM Tris--HCl, pH 9.0) and stored overnight at 4°C. Thereafter a standard protocol was followed [18] . Haemophilus influenzae hypothetical protein UHP_03526
(GI:144986114) was included as a negative control. It is an OMP derived from non--typable H. influenzae 3655 and does not bind Vn (unpublished data). UHP_03526 was expressed and purified using the same method as described for Porin D and was used to exclude the possibility of unspecific binding derived from vector sequences including the Histidine--tag (6 His), or from trace amounts of co--purified E. coli contaminants. Data analysis was performed using the Fortebio Data Analysis software 8.1 (Pall). 8
Porin D--vitronectin affinity measurements
Curves were fitted with 1:1 binding kinetics and the Kass, Kdiss, and affinity (KD) was calculated.
Western blot
OMPs were prepared by resuspending bacteria in 50 nM Tris--phosphate buffer containing 3% Empigen (Calbiochem, Merck Millipore, Darmstadt, Germany) and a protease inhibitor (Complete; Roche, Basel, Switzerland). This suspension was incubated at 37°C with glass beads and end--to--end rotation. Proteins were separated on a NuPAGE 4--12% or 10% Bis--Tris gels (Life technologies, Carlsbad, CA) and blotted as described [18] .
Flow cytometry
E. coli BL21 (DE3) containing pET16b oprD or pET16 without insert (negative control vector) were induced overnight with isopropyl--β--D--1--thiogalactopyranoside (IPTG).
Bacterial pellets were washed and resuspended to OD600=1.0 in PBS and incubated with recombinant vitronectin aa 80--396 in PBS--2% BSA followed by addition of an anti--vitronectin monoclonal antibody (mAb) VN58--1 (Abcam, Cambridge, UK). After washes, FITC--conjugated rabbit anti--mouse polyclonal Abs (Dako, Glostrup, Denmark) was added. Finally, samples were analyzed in a flow cytometer EPICS--XL (Beckman Coulter, Pasadena, CA). Gates were set to include 2 % of the background and any reading above this was considered positive. Controls were prepared in the presence of primary and secondary Abs, but in the absence of vitronectin.
Binding of P. aeruginosa to immobilized vitronectin
Glass slides were coated with 0.5 µg human plasma vitronectin and air--dried at 37 °C.
Bacteria were grown in LB medium, washed and resuspended in PBS (OD600=0.5). The slide was submerged in the bacterial suspension and incubated at 37°C for 1 h. After washing and drying, the sample was Gram--stained and the main investigator and one independent researcher counted adherent bacteria in six randomly selected fields.
Statistical analysis
Comparisons of means were evaluated with unpaired Student´s t--test. P--values ≤ 0.05 and were considered as statistically significant. Statistical analyses were performed using Graph--Pad Prism ® version 6.0 (GraphPad Software, La Jolla, CA).
Ethics statement
Permit (M193--11) was obtained from Malmö/Lund District Court (Djurförsöksetiska nämnden, Lund, Sweden) for immunization of rabbits.
Results
P. aeruginosa isolated from the respiratory tract of patients with cystic fibrosis have increased vitronectin--binding capacity
To analyse the vitronectin--binding capacity of clinical P. aeruginosa isolates, we performed a DBA with [ 125 I]--labeled vitronectin. Isolates from the airway of patients with CF (n=27) and blood isolates from bacteremic patients (n=15) were selected.
Binding of vitronectin was normalized to the reference strain P. aeruginosa PAO1 that was set to 1.0. Intriguingly, we found that airway isolates from CF patients bound significantly (p=0.025) more vitronectin in comparison to blood isolates (Fig. 1 ).
Proteomics reveals Porin D as a vitronectin receptor of P. aeruginosa
To identify vitronectin--binding proteins in the outer membrane of P. aeruginosa, OMPs from PAO1 and four selected clinical strains were separated by 2D--SDS--PAGE. A typical gel with PAO1 is exemplified in Figure 2A . Vitronectin was used as a probe and the vitronectin--binding proteins were identified by a far Western blot immunoassay (Fig.   2B ). We observed a unique spot corresponding to a putative vitronectin--binding protein with molecular mass of 50 kDa in all strains. This spot was excised from the 2D--gel,
analyzed by MALDI--TOF and subsequently identified as Porin D (GI: 15596155, PA0958
according to the Pseudomonas Genome Project [21] ). This indicated that vitronectin acquisition at the surface of P. aeruginosa involved Porin D. The protein was thereafter recombinantly expressed in E. coli (Fig. 2C) , and used for immunization of rabbits.
Resulting pAbs recognized the recombinant protein (Fig. 2D ).
Recombinant Porin D from P. aeruginosa has a high affinity for vitronectin
To confirm that the vitronectin--binding property of the putative vitronectin receptor was not an artifact, protein--protein interactions between vitronectin and recombinant Porin D were analyzed by ELISA. Porin D was coated on microtiter plates and increasing concentrations of vitronectin were added. A dose--dependent binding of vitronectin to
Porin D was observed, that is, significantly more vitronectin was bound by Porin D in comparison to the negative control. (Fig. 3A) . To further evaluate the kinetics of this interaction, we performed a Biolayer interferometry assay with vitronectin immobilized to the sensors. The interaction was analyzed with Porin D in serial dilutions starting with 1 μM. Under these experimental conditions and a vitronectin concentration of 125 nM, the dissociation constant (KD) was calculated to 3.6 nM (KD error 1.09x10 --10 ) (Fig.   3B ).
Vitronectin contains three heparin--binding domains (HBD) (Fig. 3C) . We have previously shown that Haemophilus surface fibrils (Hsf) from H. influenzae bind to the HBD3 of vitronectin (amino acids 352--374) [22] . In the present study, we used truncated vitronectin fragments to in detail test the interaction between Porin D and vitronectin (Fig. 3C) . Our results implied that Porin D bound to vitronectin between amino acid (aa) sequence 352 to 374, which corresponds to HBD 3 (Fig.  3D) . Moreover, we found that heparin completely blocked the binding of vitronectin to Porin D (Fig. 3E) , which confirmed involvement of HBDs in the Porin D--dependent vitronectin binding.
Porin D is functional and binds vitronectin at the surface of E. coli
The specific function of Porin D was further investigated using E. coli as a heterologous host. After transformation, porin D--expressing E. coli was analyzed by flow cytometry using anti--Porin D pAbs (Fig.  4A) . Porin D was readily expressed at the surface of the E.
coli--OprD transformant as opposed to the control with an empty expression vector.
Vitronectin binding was confirmed by flow cytometry after incubation with increasing concentrations of vitronectin (0--128 nM). A significantly higher vitronectin--binding capacity was observed with E. coli--OprD as compared to the negative control (Fig.  4B ).
Taken together, these results confirmed that Porin D is a surface--exposed protein that significantly attracts vitronectin at the bacterial surface.
Porin D is expressed in clinical P. aeruginosa isolates, and a Porin D--transposon insertion mutant has a decreased vitronectin binding capacity
To confirm expression of Porin D in 12 randomly selected clinical isolates, OMPs were isolated followed by Western blot using anti--Porin D pAbs. Four of those are presented in Fig.  5A . As seen in the Coomassie stained SDS--PAGE, approximately equal amounts of proteins were loaded in the gel (Fig. 5A, left panel) . Porin D was expressed in the clinical isolates at similar levels as the reference strains tested (Fig. 5A,  right (Fig.  5C) . Moreover, the importance of Porin D--dependent vitronectin binding was further demonstrated when P. aeruginosa was added to vitronectin--coated glass slides. By counting the adherent bacteria after rinsing and Gram staining, we found that the P. aeruginosa oprD transposon insertion mutant adhered significantly less to the vitronectin--coated glass slides in comparison to the wild type strain (p ≤ 0.001) (Fig. 5D--F) . Thus, Porin D mediates P. aeruginosa adhesion to soluble and to immobilized vitronectin.
Conclusions
The opportunist pathogen P. aeruginosa causes a great burden of disease, particularly to patients with CF. The host-pathogen interactions leading to the first stage of infection
have not yet been fully elucidated. In the present study, we have shown that P. Vitronectin is available in the lower respiratory tract as it is produced by respiratory epithelial cells. This production is upregulated in the airway of CF patients [13, 23] . Despite adhesion may promote the host response and clearance, our observations suggest that vitronectin--dependent adhesion may be a virulence strategy promoting colonization of the airway of CF patients. Similar mechanisms are used by e.g.
Streptococcus pneumoniae [24] . For P. aeruginosa, we speculate that adhesion is of importance at least during initial colonization and exacerbations.
To identify vitronectin--binding proteins in the outer membrane of P.
aeruginosa, we used a proteomic approach with 2D--SDS PAGE using vitronectin as a Vitronectin--binding is, however, likely to be multifactorial. We did not observe a complete reduction of the vitronectin binding capability in the transposon mutant and hence we would expect P. aeruginosa to possess other vitronectin--binding proteins.
Consequently, it is likely that the clinical strains express multiple ECM binding proteins.
Though P. aeruginosa often exists in sputum plaques, adhesion to the epithelial surface is likely an important step for successful colonization of the airway. It has previously been shown that vitronectin bridges the P. aeruginosa surface and αvβ 5--integrins of host lung epithelial cells, an interaction that ultimately contributes to the adherence and internalization of bacteria [7] . Supporting this observation, we were able to show that P.
aeruginosa interacts with vitronectin at the C--terminal (HBD--3), leaving
the RGD motif at the N--terminal free to bind integrins [25] . Recruitment of vitronectin by Porin D on the surface of P. aeruginosa may thus contribute to adherence to not only the ECM but also indirectly to the epithelial cell surface by using vitronectin as a bridging molecule.
Porin D is an OMP of approximately 50 kDa that is also known as OprD, PA0958, occD1 or Outer membrane protein D2. The crystal structure of Porin D has recently been solved [26] . Following the introduction of imipenem in clinical practice in the late 1980s, Porin D was identified as a channel for basic amino acids and imipenem [27] . Mutations in Porin D of P. aeruginosa have been shown to increase the bacterial resistance to imipenem, and worldwide it is one of the most commonly observed imipenem resistance mechanisms [28] . Porin D consists of 9 loops of which loops 2 and that lower the sensitivity to imipenem. It has recently been reported that oprD deficient strains had an increase in in vivo fitness based on gastrointestinal tract colonization and systemic dissemination [29] . The mechanisms behind systemic dissemination from the gastrointestinal tract are likely to be different to the mechanisms promoting local colonization of the respiratory tract, which is why our results are not conflicting. We hypothesize that OprD binding to Vn is of biological importance for local colonization of the respiratory tract.
In conclusion, we found that clinical isolates from the airways of CF patients bind more vitronectin in comparison to isolates cultured from blood. 
